Volv Global helps you find more of the right patients at the right time for maximum therapeutic effectiveness. This helps to accelerate product launch, “de-risk” commercial planning, and extend the product lifecycle by expanding the market to undiagnosed and misdiagnosed patients.
Identify high-need populations to drive strategic focus. Improve cohort segmentation using real-world data for optimal patient triage.
Streamline sales by directing resources to patients most likely to respond. Pinpoint those who stand to benefit quickly and significantly from new treatments.
Expand beyond diagnosed individuals to include undiagnosed or misdiagnosed patients. Intervene at the right time to maximise therapeutic effectiveness.
Match evolving market needs with deep disease understanding and competitive insights. Develop more impactful awareness and commercialisation strategies.
Commercial excellence in the face of complexity
Identifying high-need populations based on diverse and incomplete datasets.
Challenges in capturing the full care pathway, including missed or delayed diagnoses, delayed treatment, and the progression of untreated conditions.
Aligning disease understanding with market needs and competitive and evolving treatment paradigms.
Combining clinical, economic, and patient-reported data to drive strategy.
Supporting Clinical Development
We find undiagnosed and misdiagnosed patients, expanding the pool of patients for clinical trial recruitment.
We find patients before the development of traditional symptoms, before they are given conventional therapies.
We enable triage of patients according to prognosis of outcomes, e.g., fast progressors, or progressors to more acute symptoms.
We differentiate and cluster heterogeneous patient cohorts for more accurate definition of trial inclusion and exclusion criteria.
Leading AI/ML methodology to support Commercial Excellence
For commercial teams, inTrigue’s targetted engagement tools and comprehensive patient stratification capabilities offer a clearer picture of unmet needs across healthcare markets. By recognizing hidden patient clusters and forecasting disease trajectories, organizations can tailor outreach and education strategies that resonate with specific patient segments.
With its continuous learning from new data, inTrigue ensures commercial strategies remain agile—empowering teams to refine their approach, highlight early detection benefits, and drive more precise and impactful market engagement.
Real-world impact
Our technology has already made a significant difference in the lives of many patients.
Here are a few examples of how Volv Global and inTrigue have enabled earlier detection and transformed patient care:
Shaping the future today
Ready to shape the future of healthcare? Let’s explore how our machine learning solutions can accelerate diagnoses, refine patient journeys, and drive meaningful impact for those who need it most. We value your ideas and expertise, reach out now to unlock new possibilities together.
